Full-Time
Lead Product Manager; Testing Lead
WIM Operations, Account Opening & Maintenance
Posted on 9/11/2026
Wells Fargo
10,001+ employees
Nationwide banking and financial services
No salary listed
No H1B Sponsorship
Charlotte, NC, USA
Hybrid
Hybrid work schedule required.
 Product (1) |
|---|
Get referred to Wells Fargo
See people who can refer or advise you
- At least 5 years of experience in product management, product development, strategic planning, process management, or change delivery, or equivalent demonstrated through work experience, training, military experience, education.
- Own product outcomes end-to-end by identifying, prioritizing, and delivering capabilities that maximize customer and business value.
- Drive product vision, roadmap, and prioritization across complex initiatives.
- Serve as a liaison among business, technology, operations, Legal, Risk, and Compliance partners.
- Facilitate stakeholder meetings and governance forums, including agendas, decisions, action items, and meeting minutes.
- Develop business cases and executive presentations to support strategic decisions and investments.
- Use data, analytics, and insights to guide prioritization and decision-making.
- Manage product roadmaps and Jira backlogs while balancing long-term strategy with near-term delivery.
- Use generative artificial intelligence tools to accelerate research, analysis, documentation, and workflow efficiency.
- Mentor Product Owners and provide leadership across cross-functional teams.
- Experience leading end-to-end testing strategy and execution for large-scale product, technology, or regulatory initiatives.
- Strong knowledge of Agile delivery practices and hands-on experience with Jira, OpenText ALM Octane, or similar test management platforms.
- Experience developing test plans, test cases, regression testing approaches, and defect management processes for complex enterprise applications.
- Ability to lead and coordinate onshore and offshore testing teams across multiple workstreams and stakeholders.
- Experience presenting testing results, quality metrics, key risks, and mitigation strategies to senior leaders and governance forums.
- Knowledge of test automation tools, frameworks, and emerging technologies that enhance quality, speed, and scalability.
- Experience within Brokerage, Wealth and Investment Management, Account Opening and Maintenance, or other financial services businesses.
- Strong verbal, written, and interpersonal communication skills with the ability to influence partners and drive alignment across business and technology organizations.
Wells Fargo provides banking, investment, and payment services to individuals, businesses, and institutions. Its products include checking and savings accounts, loans, credit cards, wealth management, and payments, accessible through branches, online and mobile platforms, and full payment rails. The company combines a wide national footprint with a long history and a business model that integrates banking, investment, and payments, supported by a large network of branches and ATMs. Its goal is to help customers manage money, grow wealth, and move funds safely and reliably.
Company Size
10,001+
Company Stage
IPO
Headquarters
San Francisco, California
Founded
1851
Get referred to Wells Fargo
See people who can refer or advise you
Simplify's Take
What believers are saying
- March 2026 Fed termination ended the last major enforcement action on Wells Fargo.
- 2Q26 net income hit $6.4 billion, with net interest income up 5%.
- Wealth recruiting accelerated in 2026, adding Gianluca Palermo and James Taylor teams.
What critics are saying
- Wells Fargo still carries fake-accounts brand damage; adviser retention remains fragile after 2016 scandals.
- Independent advisers brought $17 billion, but technology-enabled breakaways can drain assets quickly.
- A renewed compliance lapse would trigger harsher supervision and erase the Fed-relief franchise premium.
What makes Wells Fargo unique
- June 2025 asset-cap removal restores growth optionality versus JPMorgan and BofA.
- Barry Sommers' 2020 wealth overhaul attracted $17 billion from independent advisers in 2026.
- 2Q26 revenue rose 9% to $22.6 billion, showing operating leverage under Charlie Scharf.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Parental Leave
Disability Insurance
Life Insurance
Tuition Reimbursement
Commuter Benefits
Adoption Assistance
Company News
Wells Fargo analyst Joe Quatrochi upgraded Synopsys to "Overweight" with a $475 price target, suggesting nearly 20% upside potential. The electronic design automation company's shares have fallen about 25% from their year-to-date high. Quatrochi cited accelerating demand in artificial intelligence and advanced semiconductor design automation for the upgrade. He expects the company's upcoming Analyst Day on 30 September to serve as a catalyst, with management likely outlining long-term growth initiatives and strategic progress. The analyst views Synopsys's current price-to-sales ratio of approximately 10x as attractive following the recent pullback. In its latest quarter, the company reported revenue of $2.48 billion, up 42% year-on-year, with earnings per share of $3.91.
MYR Group ( ($MYRG) ) has issued an update. On September 8, 2026, MYR Group Inc. entered into a five-year Fourth Amended and Restated Credit Agreement with a bank s...
On September 9, 2026, Principal Financial Group, Inc. , Principal Financial Services, Inc., a wholly-owned subsidiary of the Company , and Principal Life Insurance Company, a wholly-owned subsidiary...
IDEX Corporation has amended its revolving credit facility, extending the maturity date to September 3, 2031, from the previous November 1, 2027. The facility maintains its $800 million principal amount. The agreement, finalised on September 3, 2026, allows for up to $100 million in letters of credit and $50 million in same-day swingline loans. IDEX may request additional lending commitments, capped at a $400 million increase. Bank of America serves as administrative agent, with JPMorgan Chase Bank, PNC Bank, and Wells Fargo Bank as co-syndication agents. The proceeds will fund working capital and general corporate purposes, including refinancing existing debt. The agreement includes standard covenants for senior unsecured credit facilities, featuring a quarterly-tested leverage ratio and restrictions on liens and mergers. Voluntary prepayments are permitted without penalty.
Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.